In recent developments, dietary supplement manufacturers are advocating for the Food and Drug Administration (FDA) to broaden the spectrum of ingredients available for their products. This potential shift could pave the way for an increase in marketing of popular wellness items such as peptides and probiotics. On Friday, the FDA convened a public meeting to examine its existing criteria for dietary supplements, debating whether they might be extended to include non-traditional ingredients that do not originate from food, vitamins, or herbs. The FDA is set to hear insights from industry leaders, consumer advocates, and academics during this pivotal meeting.
This gathering marks the first since Robert F. Kennedy Jr. took office as the nation’s top health official last year. Kennedy has committed to ceasing the FDA’s restrictive practices concerning dietary supplements and other products favored by his Make America Healthy Again initiative. The meeting was initiated at the behest of the Natural Products Association, which has previously had conflicts with the FDA regarding new supplement ingredients. The association addressed their request in a letter submitted in January, highlighting the “cost and uncertainty” stemming from vague regulatory expectations.
Kyle Diamantas, the FDA’s leading food official, kicked off the meeting by reaffirming the agency’s dedication to “reducing red tape” to help lower operational expenses for the industry. “The industry has grown tremendously over the last 30 years, yet the regulatory framework has largely remained unchanged,” Diamantas informed attendees.
Here’s what you need to know about the current situation:
Many Wellness Products Do Not Qualify as Supplements
According to FDA regulations, dietary supplements are categorized as a type of food, with ingredients primarily sourced from plants, herbs, and other substances present in the average American diet. This stipulation has become increasingly problematic for the industry, particularly as newer wellness products often incorporate substances not traditionally associated with food.
Peptides are a prime example; these are drug-like chains of amino acids that have gained popularity among celebrities and influencers for their purported abilities to enhance muscle growth and promote youthfulness, despite limited scientific backing. While many specialty pharmacies and clinics provide peptides as injections or IV infusions, some supplement manufacturers are now also including them in capsules, gummies, and powders. However, this practice contradicts FDA regulations, as confirmed by FDA legal experts. The same is true for certain probiotics, which are marketed as aiding digestion and enhancing gut health.
Industry representatives argue that the current FDA laws do not explicitly stipulate that all ingredients must originate from food. “The hope of the meeting is that the FDA will reconsider its interpretation of what constitutes a dietary ingredient to accommodate substances not yet recognized as food,” stated Robert Durkin, a former FDA supplements program official who now provides consultation to various companies.
Nevertheless, consumer advocates caution that permitting new ingredients could significantly expand the supplement market, complicating the FDA’s regulatory oversight. “The FDA should prioritize the safety of the current market rather than allowing more chemicals and substances into supplements,” said Jensen Jose, senior regulatory counsel for the nonprofit Center for Science in the Public Interest, during his presentation at the meeting.
Supplement Makers Perceive Kennedy as an Ally
Kennedy recently expressed his enthusiasm for peptides, sharing on a podcast with Joe Rogan that he uses them to manage injuries. He has also pledged to ease FDA regulations concerning the manufacture of injectable peptides, which are currently subject to safety restrictions. Several of Kennedy’s supporters, including Gary Brecka, a self-proclaimed “longevity expert,” sell peptide injectables, patches, and nasal sprays through personal websites.
Dr. Mark Hyman, another associate of Kennedy, markets a variety of dietary supplements that claim to contain peptides through his own platform. Additional ties to the industry come from two former health advisers associated with Kennedy’s presidential campaign. Calley Means, currently a senior advisor at the Department of Health and Human Services, co-founded an online service that allows individuals to use tax-free health dollars on supplements and wellness products. Meanwhile, Dr. Casey Means — who is also President Donald Trump’s nominee for Surgeon General — reportedly earned significant income promoting supplements, probiotics, and similar products, as indicated by financial disclosures.
Supplements Have Historically Lacked Strict FDA Oversight
The FDA does not conduct reviews of dietary supplements akin to its evaluations of drugs and other medical products for safety and effectiveness. In fact, the agency does not maintain an exhaustive catalog of all supplements available in the market. With an estimated 100,000 or more supplements currently for sale, manufacturers hold the legal responsibility to ensure their products are safe and accurately advertised, as outlined by the FDA. It is important to note that supplements are prohibited from claiming to treat specific diseases or medical conditions.
The 1994 legislation establishing FDA oversight of dietary supplements also exempted these manufacturers from nutrition labeling obligations, which require scientific backing for health claims. Consequently, supplement makers can only make more general assertions, suggesting that their products support overall health and well-being.
Some former regulators deem this approach a misstep. “It permitted unauthorized, implied health claims,” remarked Mitch Zeller, who worked on FDA supplement issues during the 1990s. “Numerous claims appearing on supplement labels or in advertising are carefully phrased to avoid infringing on drug or treatment claims.” Companies can assert that their products enhance the structure or function of specific body parts, like strengthening bones, provided they include a disclaimer: “This statement has not been evaluated by the FDA.”
As the debate continues, the future regulatory landscape for dietary supplements remains uncertain, with significant implications for manufacturers and consumers alike.
